Business Context and Reporting Period
This Form 8-K was filed by Sarcos Technology and Robotics Corporation, identified in the request metadata as Palladyne AI Corp., and reports events beginning April 22, 2022. The principal event was the completion on April 25, 2022 of Sarcos’s acquisition of RE2, Inc., a robotics company.
Transaction and Key Financial Metrics
- Sarcos paid approximately $31.0 million in cash and issued approximately 10.8 million common shares as consideration; a portion of the shares was placed in escrow.
- The shares were issued in a private placement relying on the Securities Act Section 4(a)(2) exemption and are restricted securities subject to resale and holding-period limitations.
- The filing does not provide consolidated revenue, profit, cash flow, operating margins, debt, cash balances, liquidity measures, or pro forma financial results for the acquisition.
Material Changes and Corporate Actions
- RE2 became a wholly owned subsidiary through a two-step merger and was subsequently renamed RE2, LLC.
- Jorgen Pederson, RE2’s former founder and CEO, was appointed Sarcos’s Chief Operating Officer effective upon the April 25 closing.
- Sarcos amended and restated its bylaws to permit 80% of specified restricted securities received in the transaction to be released from lock-up upon the earlier of qualifying sales of at least 20 Guardian XO, Guardian XT, and/or Sapien commercial units, but not before September 24, 2022, or September 24, 2023. The prior provision referred to delivery of at least 20 Guardian XO and/or Guardian XT-DX units.
Management Compensation, Outlook, and Risks
- Mr. Pederson’s employment agreement provides for an annual base salary of $325,000, a target annual bonus equal to 35% of base salary, and a grant of approximately $3 million of restricted stock units. The RSUs vest 25% after one year and the remainder quarterly over the following three years, subject to continued service.
- Specified termination and change-in-control events may trigger severance, COBRA-related benefits, and accelerated vesting of equity awards. Benefits are conditioned on, among other matters, signing a release and complying with applicable restrictive and lock-up agreements.
- Sarcos may redeem up to 1.4 million shares of transaction consideration held by Mr. Pederson if he resigns without good reason or is terminated for cause. The redemption right lapses as to 50% of the shares on April 25, 2024 and as to an additional 2% each month thereafter.
- The filing provides no formal revenue or earnings guidance. Investors should consider integration execution, dilution from the approximately 10.8 million shares issued, restrictions and potential future release of lock-up shares, escrow matters, and the commercial ramp of the Guardian and Sapien product lines.
Most Important Facts to Verify
- Final cash and stock consideration, including the number of shares held in escrow and any post-closing adjustments.
- RE2’s historical and pro forma revenue, profitability, cash requirements, and contribution to Sarcos’s financial statements.
- The full amended bylaws and conditions governing release of restricted securities.
- The detailed terms, vesting schedule, and accounting treatment of Mr. Pederson’s RSU award and severance arrangements.
- Whether the acquisition creates additional debt, contingent liabilities, integration costs, or material purchase-accounting adjustments not described in this filing.